An early hospital discharge pathway (<48 hours) for low-risk STEMI patients was safe, with a 1.2% MACE rate compared to 1.9% in historical controls staying >48 hours.
Cohort (n=1,300)
Absolute Event Rate: 1.2% vs 1.9%
BACKGROUND Regional heart attack services have improved clinical outcomes following ST-segment elevation myocardial infarction (STEMI) by facilitating early reperfusion by primary percutaneous coronary intervention (PCI). Early discharge after primary PCI is welcomed by patients and increases efficiency of health care. OBJECTIVES This study aimed to assess the safety and feasibility of a novel early hospital discharge pathway for low-risk STEMI patients. METHODS Between March 2020 and June 2021, 600 patients who were deemed at low risk for early major adverse cardiovascular events (MACE) were selected for inclusion in the pathway and were successfully discharged in 30 days after discharge), with 0% cardiovascular mortality and MACE rates of 1.2%. This finding compared favorably with a historical group of 700 patients meeting pathway criteria who remained in the hospital for >48 hours (>48-hour control group) (mortality, 0.7%; MACE, 1.9%) both in unadjusted and propensity-matched analyses. CONCLUSIONS Selected low-risk patients can be discharged safely following successful primary PCI by using a pathway that is supported by a structured, multidisciplinary virtual follow-up schedule.
“We agree clearly that early or same day discharge after PCI or even after primary PCI (PPCI) for STEMI in a preselected low risk group is possible and should be incorporated into clinical practice based on evidence and strict patient flow algorithms.”
Rathod et al. (Wed,) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=1,300). Early hospital discharge pathway (<48 hours) with structured virtual follow-up vs. Historical control group remaining in hospital >48 hours was evaluated on Major adverse cardiovascular events (MACE). An early hospital discharge pathway (<48 hours) for low-risk STEMI patients was safe, with a 1.2% MACE rate compared to 1.9% in historical controls staying >48 hours.